DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

Roche Holding Ltd. (ADR)

NASDAQOTH: RHHBY

36.22 -0.05 (-0.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RHHBY $36.22 -0.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.66
Previous Close $36.27
Daily Range $36.22 - $36.70
52-Week Range $28.61 - $38.71
Market Cap $203.6B
P/E Ratio 0.00
Dividend (Yield) $0.00 (1.9%)
Volume 879,609
Average Daily Volume 1,120,906
Current FY EPS $2.08

Sector

Healthcare

Industry

Pharmaceuticals

Roche Holding Ltd. (ADR) (RHHBY) Description

Website:

News & Commentary

Novartis Vs. Everyone: Biologic Knockoffs

5 Pharmas Spending the Most to Develop Drugs: Merck, AstraZeneca, Roche, Bristol, and Lilly

Eli Lilly, Bristol-Myers Squibb, Roche, AstraZeneca, and Merck top the charts.

A Big Pharma Titan Prepares For the Next Generation

Roche looks to maintain leadership into a new generation of oncology.

Is Gilead About to Become an Oncology Powerhouse?

Gilead's (GILD) expanding oncology pipeline could give investors some exciting opportunities.

2 Health Care Partnerships Go Head-To-Head

While the partnership between GlaxoSmithKline (NYSE: GSK) and Ligand (NASDAQ: LGND) seems to be moving forward, the partnership between Roche (OTCMKTS: RHHBY) and PDL (NASDAQ: PDLI) has seemingly reached its end

AstraZeneca’s Alzheimer’s Drug Advances: Now What?

AstraZeneca reported disappointing fourth quarter revenues but showed progress with an Alzheimer's therapy the company has under development.

2 Deaths, 25% Plunge -- And Still A Big Upside

3 Ways Ariad Pharmaceuticals Can Salvage Iclusig

Iclusig has taken quite a few knocks since October, but there are three ways Ariad could rebuild the brand's value and boost shareholder value in the process.

Merck & Co., Inc. Shows Us How to Post Losses and Still Beat the Market

Here’s how to post a 28.6% profit loss, miss estimates, and still beat the S&P 500.

3 Stocks Poised to Dominate the Market in 2014

These companies could have a great 2014. Here's why.

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $36.22 (-0.14%)
Current stock: RHHBY
JNJ $100.22 (0.04%)
Current stock: JNJ
NVS $86.17 (-0.45%)
Current stock: NVS
GSK $55.14 (-0.29%)
Current stock: GSK